|
1
|
SV Health Investors
Boston,
Massachusetts
|
$50.3M
|
-$629K
|
-31,288
|
-1%
|
|
|
2
|
RA Capital Management
Boston,
Massachusetts
|
$28.5M
|
–
|
–
|
–
|
|
|
3
|
Vivo Capital
Palo Alto,
California
|
$26.8M
|
–
|
–
|
–
|
|
|
4
|
VHCP Management III
New York
|
$25.4M
|
–
|
–
|
–
|
|
|
5
|
Eventide Asset Management
Boston,
Massachusetts
|
$17.8M
|
–
|
–
|
–
|
|
|
6
|
VHCP Management II
New York
|
$15M
|
–
|
–
|
–
|
|
|
7
|
Deerfield Management
New York
|
$12.8M
|
–
|
–
|
–
|
|
|
8
|
Adage Capital Partners
Boston,
Massachusetts
|
$11.8M
|
+$5.93M
|
+294,813
|
+97%
|
|
|
9
|
Ghost Tree Capital
New York
|
$8.39M
|
+$4.02M
|
+200,000
|
+89%
|
|
|
10
|
InterWest Venture Management
San Francisco,
California
|
$7.68M
|
–
|
–
|
–
|
|
|
11
|
Vanguard Group
Malvern,
Pennsylvania
|
$6.73M
|
+$890K
|
+44,262
|
+15%
|
|
|
12
|
|
$5.46M
|
+$5.56M
|
+276,523
|
New
|
|
|
13
|
BVF Inc
San Francisco,
California
|
$4.99M
|
-$7.16M
|
-356,321
|
-59%
|
|
|
14
|
International Biotechnology Trust
London,
United Kingdom
|
$4.95M
|
-$60.1K
|
-2,992
|
-0.9%
|
|
|
15
|
Boxer Capital
San Diego,
California
|
$3.95M
|
–
|
–
|
–
|
|
|
16
|
Renaissance Technologies
New York
|
$3.54M
|
+$1.24M
|
+61,880
|
+53%
|
|
|
17
|
Acuta Capital Partners
Redwood City,
California
|
$3.42M
|
+$888K
|
+44,156
|
+34%
|
|
|
18
|
Samsara BioCapital
Palo Alto,
California
|
$2.96M
|
+$3.02M
|
+150,000
|
New
|
|
|
19
|
Broadfin Capital
New York
|
$2.83M
|
-$138K
|
-6,871
|
-5%
|
|
|
20
|
Fosun International
Hong Kong,
China
|
$2.44M
|
+$2.76M
|
+137,443
|
New
|
|
|
21
|
Geode Capital Management
Boston,
Massachusetts
|
$1.66M
|
+$395K
|
+19,636
|
+31%
|
|
|
22
|
Polar Capital
London,
United Kingdom
|
$1.56M
|
+$1.59M
|
+78,900
|
New
|
|
|
23
|
Barclays
London,
United Kingdom
|
$1.24M
|
+$1.26M
|
+62,707
|
+88,320%
|
|
|
24
|
Bridgeway Capital Management
Houston,
Texas
|
$1.19M
|
+$382K
|
+19,000
|
+46%
|
|
|
25
|
Wedge Capital Management
Charlotte,
North Carolina
|
$1.08M
|
-$260K
|
-12,949
|
-19%
|
|
